HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Facial Dermatoses

Subscribe to New Research on Facial Dermatoses

Also Known As:

Facial Dermatosis; Nodular Elastosis; Dermatoses, Facial; Dermatosis, Facial; Elastoidoses, Nodular; Elastoidosis, Nodular; Elastoses, Nodular; Elastosis, Nodular; Favre Racouchot Syndrome; Nodular Elastoidoses; Nodular Elastoses; Syndrome, Favre-Racouchot; Favre-Racouchot Syndrome; Nodular Elastoidosis

Networked: 23 relevant articles (3 outcomes, 4 trials/studies)

Relationship Network

Disease Context: Research Results

Skin and Connective Tissue Diseases
- Skin Diseases: 8226
  - Facial Dermatoses: 23

Related Diseases

1.	Infection
2.	Herpes Simplex
3.	Actinic Keratosis
4.	Erythropoietic Protoporphyria
5.	Perioral Dermatitis

Experts

1.	Draelos, Zoe Diana: 2 articles (11/2014 - 03/2010)
2.	Bari, Arfan Ul: 2 articles (04/2007 - 03/2005)
3.	Rahman, Simeen Ber: 2 articles (04/2007 - 03/2005)
4.	Iqbal, Zafar: 2 articles (04/2007 - 03/2005)
5.	Silapunt, Sirunya: 1 article (08/2015)
6.	Wolf, Kristin: 1 article (08/2015)
7.	Rastogi, Madhur Kant: 1 article (03/2015)
8.	Soodan, Puneet Singh: 1 article (03/2015)
9.	Mishra, Nitin: 1 article (03/2015)
10.	Gahalaut, Pratik: 1 article (03/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Facial Dermatoses:

1.	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 04/01/2007 - "Chemical peeling with salicylic acid is an effective and safe treatment modality in many superficial facial dermatoses." 03/01/2005 - "The present study is directed towards safety concerns associated with superficial chemical peeling with salicylic acid in various facial dermatoses. " 04/01/2007 - "Superficial chemical peeling with salicylic Acid in facial dermatoses." 03/01/2005 - "Chemical peeling with salicylic acid is a well tolerated and safe treatment modality in many superficial facial dermatoses." 03/01/2005 - "Tolerance and safety of superficial chemical peeling with salicylic acid in various facial dermatoses."
2.	CosmeticsIBA 01/01/2008 - "PDL offers significant cosmetic improvement in facial dermatoses in Indian patients." 03/01/2015 - "Evaluation of suspected cosmetic induced facial dermatoses with the use of Indian standard series and cosmetic series patch test." 11/01/2014 - "Facial skin care products and cosmetics can both aid or incite facial dermatoses. "
3.	SulfurIBA 08/01/2015 - "Sodium sulfacetamide is effective in the management of a variety of inflammatory facial dermatoses and often is used in combination with sulfur for a synergistic effect. " 03/01/2010 - "The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses."
4.	Sulfacetamide (Bleph)FDA LinkGeneric 08/01/2015 - "Sodium sulfacetamide is effective in the management of a variety of inflammatory facial dermatoses and often is used in combination with sulfur for a synergistic effect. " 03/01/2010 - "The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses."
5.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/01/2000 - "The aim of this study was to look at a possible relationship between the recurrent perimenstrual dermatosis - facial Herpes simplex infection and the serum concentrations of interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-alpha). "
6.	Interleukin-2 (IL2)IBA 09/01/2000 - "The aim of this study was to look at a possible relationship between the recurrent perimenstrual dermatosis - facial Herpes simplex infection and the serum concentrations of interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-alpha). "
7.	Immunoglobulins (Immunoglobulin)IBA 09/01/1974 - "Immunoglobulin and complement deposits in the skin in inflammatory facial dermatoses--an immunofluorescence study."
8.	Complement System Proteins (Complement)IBA 09/01/1974 - "Immunoglobulin and complement deposits in the skin in inflammatory facial dermatoses--an immunofluorescence study."
9.	clocortolone pivalate FDA Link 10/01/2012 - "Study results evaluating the efficacy and safety of clocortolone pivalate 0.1% cream in the treatment of adults, young children, and infants with inflammatory facial dermatoses are reported in this article. " 10/01/2012 - "The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream."
10.	Colloids (Colloid)IBA 05/01/2007 - "Well-established clinical manifestations of SE include Favre-Racouchot syndrome, cutis rhomboidalis nuchae, actinic comedonal plaques, elastomas, elastotic nodules of the ears, elastotic bands, collagenous plaques of the hands and colloid millia. " 02/01/2005 - "Recognizable clinical manifestations of solar elastosis include cutis rhomboidalis nuchae, Favre-Racouchot syndrome, actinic comedonal plaque, nodular forms such as elastomas, elastic nodule of the ear and elastotic bands, collagenous plaques of the hand, and colloid milia. " 07/01/1984 - "These changes include wrinkles, atrophy, cutis rhomboidalis nuchae, yellow papules and plaques of the face, colloid milium, telangiectasis, diffuse erythema, diffuse brown pigmentation, ecchymoses, freckles, actinic lentigo, nevi, Favre-Racouchot syndrome, poikiloderma of Civatte, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, melanoma, actinic lichen planus, actinic reticuloid, porphyria cutanea tarda, and erythropoietic protoporphyria. "

Therapies and Procedures

1.	Dye Lasers 01/01/2008 - "Efficacy of pulsed dye laser in cosmetically distressing facial dermatoses in skin types IV and V."
2.	Gas Lasers 03/01/2014 - "Favre-Racouchot syndrome: a novel two-step treatment approach using the carbon dioxide laser." 01/01/2010 - "Combined treatment of Favre-Racouchot syndrome with a superpulsed carbon dioxide laser: report of 50 cases."
3.	Skin Care 11/01/2014 - "Facial skin care products and cosmetics can both aid or incite facial dermatoses. " 08/01/2011 - "Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach."
4.	Curettage 05/01/1982 - "Curettage for removal of the comedones and cysts of the Favre-Racouchot syndrome."